NEW YORK, Nov 29 – ProteinChip-maker Ciphergen Biosystems said Wednesday that it would collaborate with Johns Hopkins University School of Medicine to develop proteomic diagnostic tests for cancer.

Ciphergen will use its ProteinChip System to discover and validate protein biomarkers in cancer serum samples provided by Johns Hopkins. The university will also provide the clinical expertise of its physicians and scientists.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.

The New York Times reports on the shifting interpretations of what some genetic variants mean over time.

In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.

MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.